Publication:
Population susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011

dc.contributor.authorHoschler, K
dc.contributor.authorThompson, C
dc.contributor.authorCasas Flecha, Inmaculada
dc.contributor.authorEllis, J
dc.contributor.authorGaliano, M
dc.contributor.authorAndrews, N
dc.contributor.authorZambon, M
dc.contributor.funderSanofies_ES
dc.contributor.funderBaxter CSL Ltd Australiaes_ES
dc.contributor.funderRochees_ES
dc.date.accessioned2023-02-21T08:39:06Z
dc.date.available2023-02-21T08:39:06Z
dc.date.issued2013-09-05
dc.description.abstractAge-stratified sera collected in 2004, 2008 and 2010 in England were evaluated for antibody to swine influenza A(H3N2) and A(H1N1) viruses from the United States or Europe as a measure of population susceptibility to the emergence of novel viruses. Children under 11 years of age had little or no measurable antibody to recent swine H3N2 viruses despite their high levels of antibody to recent H3N2 seasonal human strains. Adolescents and young adults (born 1968–1999) had higher antibody levels to swine H3N2 viruses. Antibody levels to swine H3N2 influenza show little correlation with exposure to recent seasonal H3N2 (A/Perth/16/2009) strains, but with antibody to older H3N2 strains represented by A/Wuhan/359/1995. Children had the highest seropositivity to influenza A(H1N1)pdm09 virus, and young adults had the lowest antibody levels to A/Perth/16/2009. No age group showed substantial antibody levels to A/Aragon/RR3218/2008, a European swine H1N1 virus belonging to the Eurasian lineage. After vaccination with contemporary trivalent vaccine we observed evidence of boosted reactivity to swine H3N2 viruses in children and adults, while only a limited boosting effect on antibody levels to A/Aragon/RR3218/2008 was observed in both groups. Overall, our results suggest that different vaccination strategies may be necessary according to age if swine viruses emerge as a significant pandemic threat.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipHPA has received grant funding from Sanofi Pasteur, Baxter, CSL Ltd Australia and Roche. No other authors have competing interests to declare.es_ES
dc.format.number36es_ES
dc.format.page20578es_ES
dc.format.volume18es_ES
dc.identifier.citationEuro Surveill. 2013 Sep 5;18(36):pii=20578.es_ES
dc.identifier.doi10.2807/1560-7917.es2013.18.36.20578es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID24079379es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15517
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.es2013.18.36.20578es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdolescentes_ES
dc.subject.meshAdultes_ES
dc.subject.meshAgedes_ES
dc.titlePopulation susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione2df6e55-f1d3-423b-a72f-fd9a69cf5915
relation.isAuthorOfPublication.latestForDiscoverye2df6e55-f1d3-423b-a72f-fd9a69cf5915

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PopulationSusceptibilityNorthAmerican_2013.pdf
Size:
367.8 KB
Format:
Adobe Portable Document Format
Description: